How do I install the Jes Pa Screening Indication skill?

Run npx skillmds@latest add dromlakhani/jes-pa-screening-indication in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Jes Pa Screening Indication safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Jes Pa Screening Indication?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Jes Pa Screening Indication free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Jes Pa Screening Indication?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Jes Pa Screening Indication by dromlakhani

Name: Jes Pa Screening Indication
Rating: 4.2 (5 reviews)
Author: dromlakhani

Jes Pa Screening Indication

Determines whether a hypertensive patient should be screened for primary aldosteronism based on clinical features associated with higher PA prevalence. Triggered when a clinician asks 'Should I screen this hypertensive patient for PA?' or observes spontaneous hypokalemia, resistant hypertension, hypertension onset before age 40, adrenal tumor, young-onset stroke, or sleep apnea syndrome.

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Determine when to screen for primary aldosteronism in hypertensive patients

STEP 1 — Gather Information

Confirm hypertension diagnosis and collect: serum potassium (spontaneous hypokalemia?), blood pressure readings and medication count (resistant hypertension?), age at hypertension onset, imaging for adrenal tumor, history of stroke before age 40, and sleep apnea evaluation.

STEP 2 — Rule In / Rule Out

Is the patient hypertensive? If no → do not screen for PA; if yes → proceed to assess for high-prevalence features.

STEP 3 — Classify or Stratify

Does the hypertensive patient have any of: spontaneous hypokalemia, resistant hypertension, hypertension onset before 40 years, adrenal tumor on imaging, stroke at a young age, or sleep apnea syndrome? If yes → classify as high suspicion; if no → classify as routine suspicion.

STEP 4 — Decide

High suspicion → screen for PA promptly (e.g., ARR ≥200 with PAC ≥60 pg/mL). Routine suspicion → screen for PA as part of standard hypertension evaluation per guideline recommendation.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on hypokalemia to exclude PA; many PA patients have normal potassium. Avoid screening in normotensive individuals unless secondary hypertension is suspected. Do not delay screening in patients with resistant hypertension or adrenal incidentaloma.

Concrete Clinical Example

A 45‑year‑old with hypertension on three medications, BP 158/96 mmHg, and incidental 1.2 cm adrenal nodule on abdominal CT is identified as high suspicion (adrenal tumor + resistant hypertension) and undergoes ARR screening.

Source: Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021, Japan Endocrine Society, 2021.

---name: jes-pa-screening-indicationdescription: Determines whether a hypertensive patient should be screened for primary aldosteronism based on clinical features associated with higher PA prevalence. Triggered when a clinician asks 'Should I screen this hypertensive patient for PA?' or observes spontaneous hypokalemia, resistant hypertension, hypertension onset before age 40, adrenal tumor, young-onset stroke, or sleep apnea syndrome.---# Determine when to screen for primary aldosteronism in hypertensive patients## STEP 1 — Gather InformationConfirm hypertension diagnosis and collect: serum potassium (spontaneous hypokalemia?), blood pressure readings and medication count (resistant hypertension?), age at hypertension onset, imaging for adrenal tumor, history of stroke before age 40, and sleep apnea evaluation.## STEP 2 — Rule In / Rule OutIs the patient hypertensive? If no → do not screen for PA; if yes → proceed to assess for high-prevalence features.## STEP 3 — Classify or StratifyDoes the hypertensive patient have any of: spontaneous hypokalemia, resistant hypertension, hypertension onset before 40 years, adrenal tumor on imaging, stroke at a young age, or sleep apnea syndrome? If yes → classify as high suspicion; if no → classify as routine suspicion.## STEP 4 — DecideHigh suspicion → screen for PA promptly (e.g., ARR ≥200 with PAC ≥60 pg/mL). Routine suspicion → screen for PA as part of standard hypertension evaluation per guideline recommendation.## Clinical Guardrails / Mimics / PitfallsDo not rely solely on hypokalemia to exclude PA; many PA patients have normal potassium. Avoid screening in normotensive individuals unless secondary hypertension is suspected. Do not delay screening in patients with resistant hypertension or adrenal incidentaloma.## Concrete Clinical ExampleA 45‑year‑old with hypertension on three medications, BP 158/96 mmHg, and incidental 1.2 cm adrenal nodule on abdominal CT is identified as high suspicion (adrenal tumor + resistant hypertension) and undergoes ARR screening.**Source:** Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021, Japan Endocrine Society, 2021.

Frequently asked questions